Bitan, M <br/><br/>
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Jul 2006 
 - 712-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1083-8791 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2006.03.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alemtuzumab<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--administration & dosage<br/>Antilymphocyte Serum--therapeutic use<br/>Busulfan--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cyclophosphamide--therapeutic use<br/>Fanconi Anemia--therapy<br/>Female<br/>Graft vs Host Disease--etiology<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Histocompatibility Testing<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Myeloablative Agonists--therapeutic use<br/>Transplantation Conditioning--methods<br/>Treatment Outcome<br/>Vidarabine--analogs & derivatives